Highly sensitive hepatitis C virus RNA detection methods: molecular backgrounds and clinical significance

This publication has 18 references indexed in Scilit:

• Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
  New England Journal of Medicine, 2002
• Transcription-mediated amplification is more sensitive than conventional PCR-based assays for detecting residual serum HCV RNA at end of treatment
  American Journal of Gastroenterology, 2001
• Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
  Published by Elsevier ,2001
• A Randomized, Double–Blind Trial Comparing Pegylated Interferon Alfa–2B to Interferon Alfa–2B As Initial Treatment for Chronic Hepatitis C
  Hepatology, 2001
• Ultracentrifugation and concentration of a large volume of serum for HCV RNA during treatment may predict sustained and relapse response in chronic HCV infection
  Journal of Medical Virology, 1999
• EASL International Consensus Conference on Hepatitis CParis, 26–27 February 1999Consensus Statement
  Journal of Hepatology, 1999
• Prognosis of Chronic Hepatitis C: Results of A Large, Prospective Cohort Study
  Hepatology, 1998
• Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C
  New England Journal of Medicine, 1998
• National Institutes of Health Consensus Development Conference Panel statement: Management of hepatitis C
  Hepatology, 1997
• The Natural History of Community-Acquired Hepatitis C in the United States
  New England Journal of Medicine, 1992